Difficulty: Medium
Average Score: 89%
Practice
Which of the following drugs is contraindicated in a patient with porphyria?
Correct answer
D
Rationale
In the context of pharmacology of CNS drugs, it is crucial to understand the contraindications for certain medications to ensure safe and effective treatment for patients. Porphyria is a group of disorders characterized by the abnormal accumulation of porphyrins in the body, which can lead to symptoms such as abdominal pain, neurological disturbances, and skin sensitivity to light.
Phenobarbital (Option D) is contraindicated in patients with porphyria because it can exacerbate the symptoms of the condition by inducing the enzymes involved in heme synthesis, leading to increased porphyrin production.
Option A, Zolpidem, is a sedative-hypnotic often used for insomnia and is not contraindicated in porphyria.
Option B, Chloral hydrate, is a sedative-hypnotic that is also not specifically contraindicated in porphyria.
Option C, Buspirone, is an anxiolytic agent that does not have a direct contraindication in porphyria.
Educationally, understanding drug contraindications in specific patient populations is crucial for healthcare providers to prevent adverse reactions and ensure the safety of their patients. It highlights the importance of considering individual patient characteristics and medical history when prescribing medications, thereby emphasizing the principles of personalized medicine in pharmacology practice.
Phenobarbital (Option D) is contraindicated in patients with porphyria because it can exacerbate the symptoms of the condition by inducing the enzymes involved in heme synthesis, leading to increased porphyrin production.
Option A, Zolpidem, is a sedative-hypnotic often used for insomnia and is not contraindicated in porphyria.
Option B, Chloral hydrate, is a sedative-hypnotic that is also not specifically contraindicated in porphyria.
Option C, Buspirone, is an anxiolytic agent that does not have a direct contraindication in porphyria.
Educationally, understanding drug contraindications in specific patient populations is crucial for healthcare providers to prevent adverse reactions and ensure the safety of their patients. It highlights the importance of considering individual patient characteristics and medical history when prescribing medications, thereby emphasizing the principles of personalized medicine in pharmacology practice.